CVE:VIV Avivagen (VIV) Stock Price, News & Analysis → A once-in-a-century investment opportunity (From Stansberry Research) (Ad) Free VIV Stock Alerts C$0.0050 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.08Volume2,820 shsAverage Volume49,827 shsMarket CapitalizationC$388,450.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Avivagen alerts: Email Address Ad Manward PressMy 3 Top CryptocurrenciesMore than a decade after the first Bitcoin was mined, people are finally realizing something very important... Cryptocurrencies are about more than just creating digital money.Let me tell you all about them here. About Avivagen Stock (CVE:VIV)Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.Read More VIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIV Stock News HeadlinesMarch 6, 2024 | investing.comAvivagen Inc (VIV)March 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - VIVFebruary 20, 2024 | theglobeandmail.comAvivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)January 3, 2024 | finance.yahoo.comPure Harvest Corporate Group, Inc. (PHCG)November 5, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Monday (VIV)October 17, 2023 | finance.yahoo.comAvivagen Announces New 500Kg Order for OxC-beta™August 25, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Friday (VIV)July 31, 2023 | technews.tmcnet.comAvivagen Provides Corporate UpdatesJuly 29, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc up on Friday (VIV)July 24, 2023 | finance.yahoo.comAvivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock ProductJuly 19, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Tuesday (VIV)July 15, 2023 | theglobeandmail.comAvivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)June 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Monday (VIV)May 25, 2023 | msn.comAn existing Avivagen customer increases order sizeMay 25, 2023 | finance.yahoo.comAvivagen Announces Significant Increase in Sales to an Existing CustomerMay 23, 2023 | sg.finance.yahoo.comAvivagen Inc. (VIV.V)May 18, 2023 | tmcnet.comAvivagen Announces Review of Strategic AlternativesApril 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Thursday (VIV)April 19, 2023 | finance.yahoo.comAvivagen Announces AGM ResultsApril 7, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Thursday (VIV)April 6, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Wednesday (VIV)March 28, 2023 | finance.yahoo.comAvivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSOMarch 18, 2023 | finance.yahoo.comAvivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)February 21, 2023 | msn.comAvivagen reports FY resultsFebruary 21, 2023 | finance.yahoo.comAvivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate GrowthSee More Headlines Receive VIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/14/2024Next Earnings (Estimated)6/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VIV CUSIPN/A CIKN/A Webwww.avivagen.com Phone613-949-8164FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,640,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-193.44% Debt Debt-to-Equity Ratio2,402.32 Current Ratio0.03 Quick Ratio0.30 Sales & Book Value Annual SalesC$403,780.00 Price / Sales0.96 Cash FlowC$0.00 per share Price / Cash Flow12.14 Book ValueC($0.12) per share Price / Book-0.04Miscellaneous Outstanding Shares77,690,000Free FloatN/AMarket CapC$388,450.00 OptionableNot Optionable Beta1.06 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. G. F. Kym Anthony (Age 68)CEO & Vice Chairman Comp: $361.06kDr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & DirectorMr. Ira LevyInterim Chief Financial OfficerDr. James Nickerson Ph.D.President and Executive VP of Business Development & Product InnovationMr. Drew BasekDirector of Investor RelationsMs. Tracy Gillett BVSCDirector of Companion Animal & Marketing ManagerMore ExecutivesKey CompetitorsNeutriSci InternationalCVE:NUSugarBud Craft GrowersCVE:SUGRAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJView All Competitors VIV Stock Analysis - Frequently Asked Questions How have VIV shares performed in 2024? Avivagen's stock was trading at C$0.01 at the start of the year. Since then, VIV stock has increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is Avivagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 18th 2024. View our VIV earnings forecast. What other stocks do shareholders of Avivagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV). How do I buy shares of Avivagen? Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VIV) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredMy 3 Top CryptocurrenciesMore than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avivagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.